This inventor holds 1 USPTO granted patent. Top assignee: Universitá Degli Studi Di Siena. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Manuela Mancini: Innovator in Cancer Treatment
Introduction
Manuela Mancini is a prominent inventor based in Bologna, Italy. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic compounds. Her work focuses on the inhibition of 14-3-3 proteins, which play a crucial role in tumor progression.
Latest Patents
Manuela Mancini holds 1 patent for her invention titled "Non peptidic 14-3-3 inhibitors and the use thereof." This patent refers to compounds that exhibit inhibitory activity against 14-3-3 proteins, specifically targeting their application in the treatment of tumors, including chronic myeloid leukemia. The invention also outlines methods for identifying these protein inhibitors, showcasing her commitment to advancing cancer therapies.
Career Highlights
Mancini is affiliated with the Università Degli Studi Di Siena, where she continues her research and development efforts. Her academic background and dedication to scientific inquiry have positioned her as a key figure in her field.
Collaborations
Throughout her career, Manuela has collaborated with esteemed colleagues, including Maria Alessandra Santucci and Maurizio Botta. These partnerships have enhanced her research and contributed to the advancement of innovative cancer treatments.
Conclusion
Manuela Mancini's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her contributions through her patent and collaborations highlight her role as a leading inventor in the fight against cancer.